Next-Generation Sequencing in Precision Medicine Market Size, Trends, and Competitive Landscape by 2034
Market OverviewIn 2024, the next-generation sequencing (NGS) in precision medicine market was valued at approximately USD 6.21 billion. Supported by the accelerating adoption of genomic technologies across oncology, rare disease diagnostics, and pharmacogenomics, the market is anticipated to witness substantial growth, reaching nearly USD 32.01 billion by 2034. This expansion...
0 Yorum
0 Paylar
English